GO:0046006 regulation of activated T cell proliferation: Immune Checkpoint Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046006 describes any process that modulates the frequency, rate or extent of activated T cell proliferation, a central checkpoint in adaptive immunity.
• T cell receptor and costimulatory signals, especially CD28 and CTLA4, set the threshold for activation and subsequent clonal expansion.
• mTORC1 signaling and ribosomal biosynthesis are reciprocally coupled to cell cycle progression in activated T cells, linking nutrient sensing to proliferation.
• Glycan checkpoints and complement regulators fine-tune T cell activity and alloimmune responses, showing that regulation extends beyond classical costimulation.
• Dysregulation of this process contributes to autoimmunity, transplant rejection, cancer immune escape and inflammatory diseases.
• CRISPR knockout, point mutation, knock-in and overexpression models enable causal dissection of regulators of activated T cell proliferation.
Description
Regulation of activated T cell proliferation (GO:0046006) is the biological process that controls how many times an activated T lymphocyte divides and how quickly it expands after antigen recognition. This process is essential for mounting effective immunity while preventing excessive or self-reactive responses, and it integrates signals from the T cell receptor, costimulatory receptors such as CD28 and CTLA4, cytokine receptors, metabolic pathways and epigenetic regulators. Because the size and persistence of a T cell clone determine protective immunity versus immunopathology, the mechanisms that modulate activated T cell proliferation are intensively studied in infection, autoimmunity, transplantation and cancer. Recent work has shown that reciprocal regulation of mTORC1 signaling and ribosomal biosynthesis determines cell cycle progression in activated T cells, directly connecting nutrient and growth signals to proliferative fate. Other studies have implicated AP-1 transcription factors such as JunB in T cell differentiation programs that shape the functional outcome of activation. Glycan-based checkpoints and complement regulators further illustrate that activated T cell proliferation is controlled by a broad network of surface and soluble cues. Understanding GO:0046006 therefore provides a framework for identifying therapeutic targets that can either boost protective T cell expansion or restrain pathogenic proliferation.
regulation of activated T cell proliferation At A Glance
| GO ID | GO:0046006 |
|---|---|
| GO term | regulation of activated T cell proliferation |
| Ontology | biological_process |
| Synonym | regulation of activated T-cell proliferation; regulation of activated T lymphocyte proliferation; regulation of activated T-lymphocyte proliferation |
| Definition | Any process that modulates the frequency, rate or extent of activated T cell proliferation. |
| Major function | Controls the magnitude and duration of clonal expansion of activated T lymphocytes. |
| Biological context | Adaptive immunity, costimulation, cytokine signaling, metabolic and epigenetic regulation. |
| Disease relevance | Autoimmunity, transplant rejection, cancer immune escape, inflammatory diseases. |
| Experimental approaches | CRISPR KO/point mutation/knock-in/overexpression, flow cytometry, metabolic assays, transcriptomics. |
What Is GO:0046006?
According to the Gene Ontology, GO:0046006 (regulation of activated T cell proliferation) is defined as any process that modulates the frequency, rate or extent of activated T cell proliferation. In practical terms, it covers the molecular and cellular events that increase or decrease the division rate of T lymphocytes that have already received an activation signal, without being restricted to a single receptor, cytokine or metabolic pathway.
Why Is regulation of activated T cell proliferation Important in Cell Biology?
Regulation of activated T cell proliferation is a decisive checkpoint that determines whether an immune response is protective, self-limiting or pathogenic. Because activated T cells must expand rapidly to control pathogens but must also contract to avoid autoimmunity and chronic inflammation, the pathways that modulate their proliferation are central to immunology and immunotherapy. Defects in these regulatory circuits can permit tumor immune escape, whereas excessive proliferation can drive allograft rejection and autoimmune tissue damage.
• Sets the threshold for clonal expansion after T cell receptor engagement and costimulation.
• Integrates metabolic and ribosomal biosynthetic capacity with cell cycle entry in activated T cells.
• Shapes T helper differentiation programs through transcription factors such as JunB.
• Modulates alloimmune responses and transplant rejection through complement regulators.
• Influences Th9 differentiation and IL-9-driven inflammatory diseases.
• Is targeted by glycan checkpoints that tune T cell activity and function.
• Contributes to tumor immune escape when CD8+ T cell expansion is suppressed.
• Provides a therapeutic window for modulating immunity in cancer, autoimmunity and transplantation.
• Can be dissected causally with CRISPR-based genome editing in primary and model T cells.
• Serves as a readout for immunometabolic and epigenetic interventions.
What Happens During regulation of activated T cell proliferation?
Antigen recognition and costimulatory threshold
In simple terms: A T cell first needs to recognize its antigen and receive a second confirmatory signal before it starts dividing.
Activation begins when the T cell receptor engages peptide-MHC and receives costimulatory signals, with CD28 providing positive signals and CTLA4 acting as a negative regulator that raises the threshold for proliferation. The balance between these signals determines whether the T cell enters the cell cycle or becomes anergic, making costimulation a primary node in GO:0046006.
Metabolic and ribosomal licensing for division
In simple terms: Before a T cell can divide, it must build enough proteins and energy-producing machinery.
Activated T cells require coordinated mTORC1 signaling and ribosomal biosynthesis to support cell cycle progression, and reciprocal regulation between these processes determines whether proliferation proceeds. This metabolic licensing step couples nutrient availability and growth factor signals to the proliferative program, ensuring that division occurs only when biosynthetic capacity is sufficient.
Transcriptional and epigenetic control of expansion
In simple terms: Gene expression programs decide how long and how vigorously a T cell clone expands.
Transcription factors such as JunB regulate T cell differentiation and influence the functional outcome of activation, thereby shaping the proliferative response. Epigenetic remodeling mechanisms, including MRG15/TIP60-associated complexes described in cardiac regeneration studies, illustrate how chromatin-level regulation can influence proliferative programs in adjacent biological contexts.
Surface and soluble checkpoint modulation
In simple terms: Molecules on the T cell surface and in its environment can put the brakes on or accelerate division.
Glycans act as key checkpoints of T cell activity and function, modulating receptor signaling and proliferative capacity. Complement regulators also influence T cell alloimmunity, showing that soluble and membrane-bound regulators outside the classical costimulatory axis contribute to the control of activated T cell proliferation.
Contraction and resolution of the response
In simple terms: After the threat is controlled, the expanded T cell population must shrink to prevent damage.
Regulation of activated T cell proliferation includes negative feedback that limits clonal expansion once antigen is cleared, preventing persistent inflammation and autoimmunity. Dysregulation of this contraction phase is linked to pathological immune activation and to immune escape in cancer, where CD8+ T cell exclusion and PD-L1 upregulation blunt effective proliferation.
Key Genes Involved in GO:0046006 regulation of activated T cell proliferation
The following genes and proteins represent major nodes through which regulation of activated T cell proliferation (GO:0046006) is executed or modulated in published studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CD28 | Provides positive costimulatory signal for T cell activation and proliferation | Target for modulating activation thresholds in autoimmunity and transplantation |
| CTLA4 | Negative regulator that raises the threshold for activated T cell proliferation | Checkpoint target in cancer immunotherapy and autoimmunity |
| MTOR | Kinase integrating nutrient and growth signals with cell cycle progression | Central node linking metabolism to activated T cell proliferation |
| JUNB | AP-1 transcription factor regulating T cell differentiation | Candidate for dissecting transcriptional control of activation outcomes |
| MRG15 | Chromatin-associated factor in epigenetic remodeling complexes | Model for epigenetic influence on proliferative programs |
| TIP60 | Histone acetyltransferase in epigenetic remodeling complexes | Tool for studying chromatin regulation of proliferation |
| PD-L1 | Ligand that suppresses CD8+ T cell activity and expansion | Target for understanding tumor immune escape |
| PGRN | Progranulin, induces PD-L1 and promotes CD8+ T cell exclusion | Model for tumor microenvironment-mediated suppression |
| IL9 | Cytokine linked to Th9 differentiation and inflammatory diseases | Readout for metabolic regulation of T helper subsets |
| Complement regulators | Modulate T cell alloimmunity and proliferation | Targets in transplant rejection research |
| Glycan-modifying enzymes | Control glycan checkpoints of T cell activity | Emerging area for immunomodulation |
| Ribosomal biosynthesis genes | Support protein synthesis for cell cycle progression | Readouts for metabolic licensing of proliferation |
| mTORC1 components | Signal to ribosomal biogenesis and cell cycle entry | Core pathway for immunometabolic studies |
| CD4+ Tregs | Regulate T cell responses and tissue growth via epigenetic remodeling | Model for regulatory T cell control of proliferation |
| JunB targets | Mediate AP-1-dependent differentiation programs | Candidate network for functional genomics |
| PD-1/PD-L1 axis | Suppresses activated T cell proliferation in tumors | Therapeutic target in immuno-oncology |
| Th9-associated transcription factors | Drive IL-9-producing T cell differentiation | Model for metabolic control of T helper proliferation |
How Is regulation of activated T cell proliferation Regulated?
Regulation of activated T cell proliferation is controlled by layered mechanisms including costimulatory and coinhibitory receptors such as CD28 and CTLA4, metabolic signaling through mTORC1 and ribosomal biosynthesis, transcriptional programs involving AP-1 factors like JunB, epigenetic remodeling complexes, glycan checkpoints, and complement regulators. These layers allow the immune system to scale T cell expansion to the threat while limiting collateral damage.
regulation of activated T cell proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PGRN | Breast cancer immune escape via PD-L1 and CD8+ T cell exclusion | Knockout or overexpression in tumor-associated macrophage and T cell co-culture |
| CTLA4 | Autoimmunity and cancer immunotherapy response | Point mutation or knockout in primary T cells |
| MTOR | Immunometabolic control of T cell proliferation | Knockout or rapamycin-treated T cell models |
| JUNB | T cell differentiation and inflammatory responses | Knockout and overexpression in T helper subsets |
| IL9 | Th9-driven inflammatory diseases | Knock-in reporter and cytokine profiling models |
Cancer immune escape
Tumors can suppress activated T cell proliferation through upregulation of PD-L1 on tumor-associated macrophages and exclusion of CD8+ T cells, as shown in breast cancer models where progranulin drives immune escape. This makes GO:0046006 a key process for understanding resistance to immunotherapy and for designing strategies to restore T cell expansion.
Transplant rejection and alloimmunity
Complement regulation of T cell alloimmunity demonstrates that regulators of activated T cell proliferation influence graft rejection. Modulating these pathways could reduce alloimmune responses while preserving protective immunity.
Autoimmunity and inflammatory diseases
Excessive or poorly controlled activated T cell proliferation contributes to autoimmune and inflammatory pathology, and metabolic regulation of Th9 differentiation illustrates how specific T helper subsets are linked to IL-9-driven diseases. Targeting the regulatory nodes of GO:0046006 may provide therapeutic benefit in these conditions.
Immunometabolic disorders
Because mTORC1 signaling and ribosomal biosynthesis are reciprocally coupled to cell cycle progression in activated T cells, disturbances in these pathways can impair or exaggerate T cell expansion. This links GO:0046006 to immunometabolic disease states and to interventions that alter nutrient sensing.
From regulation of activated T cell proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for activated T cell proliferation? | CRISPR knockout in primary T cells or Jurkat cells |
| Does a specific point mutation alter costimulatory signaling? | CRISPR point mutation knock-in in T cell lines |
| Does a disease-associated variant change proliferation? | Knock-in of the variant with functional proliferation assays |
| Where and when is a regulator expressed during activation? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression of a regulator enhance or suppress expansion? | CRISPR overexpression or lentiviral overexpression |
| Which pathways cooperate to control proliferation? | CRISPR library screening with proliferation readouts |
How to Study the regulation of activated T cell proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry with CFSE | Division history and proliferation rate | Quantifying activated T cell proliferation |
| Phospho-flow | Signaling activation states | Costimulatory and cytokine pathway analysis |
| RNA-seq | Transcriptional programs | Identifying regulators of proliferation |
| ATAC-seq / ChIP-seq | Chromatin accessibility and factor binding | Epigenetic control of proliferation |
| Metabolic assays | mTORC1 activity and biosynthesis | Immunometabolic licensing |
| CRISPR library screen | Gene requirement for proliferation | Unbiased discovery of regulators |
| Cytokine profiling | Effector differentiation | Linking proliferation to function |
| Co-culture assays | Immune suppression or activation | Tumor or transplant models |
Flow cytometry and proliferation tracking
Flow cytometry with dye dilution or CFSE labeling measures the frequency and rate of activated T cell division, providing a direct readout of GO:0046006. Surface staining for activation markers and intracellular staining for cytokines can link proliferation to functional differentiation.
Metabolic and ribosomal profiling
Assays of mTORC1 activity, ribosomal biogenesis and protein synthesis reveal the metabolic licensing required for cell cycle progression in activated T cells. These methods connect nutrient sensing to proliferative outcomes.
Transcriptomic and epigenomic analysis
RNA-seq and chromatin profiling identify transcriptional and epigenetic programs that regulate activated T cell proliferation, including AP-1 factor targets and remodeling complexes. These approaches can nominate candidate regulators for functional testing.
CRISPR screening and functional genomics
Pooled CRISPR screens with proliferation readouts enable unbiased discovery of genes that modulate activated T cell expansion. Hits can be validated individually with knockout, point mutation or overexpression models.
How CRISPR Can Be Used to Study GO:0046006 regulation of activated T cell proliferation
Knockout
CRISPR knockout of candidate genes in primary T cells or T cell lines can determine whether a regulator is required for activated T cell proliferation. Loss-of-function screens and validation experiments have identified metabolic and signaling dependencies in this process.
Point Mutation
Point mutation knock-in allows precise testing of disease-associated or signaling-critical residues in genes such as CTLA4 or mTOR pathway components. This approach distinguishes catalytic, binding and regulatory functions within the same gene.
Knock-in
Knock-in of reporters, tags or disease variants enables tracking of regulator expression and function during activation. Tagged knock-in models are particularly useful for chromatin and transcription factor studies.
Overexpression
Overexpression of candidate regulators can test sufficiency for enhancing or suppressing activated T cell proliferation. This is valuable for validating gain-of-function mechanisms suggested by tumor or autoimmune models.
How EDITGENE Supports regulation of activated T cell proliferation Research
Researchers studying regulation of activated T cell proliferation-related genes often need to determine whether a candidate gene is causally involved in controlling T cell expansion, and CRISPR-based models provide the most direct way to test this.
Contact EDITGENE today to design your custom CRISPR model for regulation of activated T cell proliferation research.
Frequently Asked Questions About regulation of activated T cell proliferation
What is GO:0046006?
GO:0046006 is the Gene Ontology term for regulation of activated T cell proliferation, defined as any process that modulates the frequency, rate or extent of activated T cell proliferation.
What genes are involved in regulation of activated T cell proliferation?
Key genes include CD28, CTLA4, MTOR, JUNB, MRG15, TIP60, PD-L1 and PGRN, among others identified in published studies.
Why is regulation of activated T cell proliferation important?
It determines the size and duration of T cell clonal expansion, which is critical for protective immunity and for preventing autoimmunity and transplant rejection.
How does mTORC1 regulate activated T cell proliferation?
mTORC1 signaling is reciprocally coupled with ribosomal biosynthesis to license cell cycle progression in activated T cells.
What role does CTLA4 play in activated T cell proliferation?
CTLA4 acts as a negative regulator that raises the threshold for T cell activation and proliferation.
How do glycans regulate T cell activity?
Glycans act as key checkpoints of T cell activity and function, modulating receptor signaling and proliferative capacity.
Can CRISPR be used to study regulation of activated T cell proliferation?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models are widely used to dissect regulators of this process.
What diseases are linked to dysregulated activated T cell proliferation?
Cancer immune escape, transplant rejection, autoimmunity and inflammatory diseases such as IL-9-driven conditions have been linked to dysregulation of this process.
What methods measure activated T cell proliferation?
Flow cytometry with dye dilution, metabolic assays, transcriptomics and CRISPR screens are commonly used to measure and dissect this process.
How does complement regulate T cell alloimmunity?
Complement regulators modulate T cell alloimmune responses and influence the proliferation of activated T cells.
Conclusion
Regulation of activated T cell proliferation (GO:0046006) is a central biological process that integrates costimulation, metabolism, transcription and epigenetic control to determine the magnitude of T cell expansion. Its dysregulation underlies cancer immune escape, transplant rejection and inflammatory disease, making it a high-value target for therapeutic intervention. CRISPR-based knockout, point mutation, knock-in and overexpression models, combined with functional genomics and metabolic profiling, provide the tools needed to dissect this process and translate findings into new immunotherapies.
References
- 1. Rosenlehner T et al.. 2024. Reciprocal regulation of mTORC1 signaling and ribosomal biosynthesis determines cell cycle progression in activated T cells.. Sci Signal 17(859):eadi8753 PMID: 39436996
- 2. Hou Y et al.. 2025. CD4(+) Tregs Regulate Heart Growth and Regeneration Through MRG15/TIP60-Mediated Epigenomic Remodeling in Proliferating Cardiomyocytes.. Circulation 152(23):1634-1656 PMID: 41251000
- 3. Katagiri T et al.. 2021. Regulation of T cell differentiation by the AP-1 transcription factor JunB.. Immunol Med 44(3):197-203 PMID: 33470914
- 4. Raedler H et al.. 2011. Complement regulation of T-cell alloimmunity.. Curr Opin Organ Transplant 16(1):54-60 PMID: 21157343
- 5. Peesari S et al.. 2025. Metabolic regulation of Th9 cell differentiation: insights for IL-9-driven diseases.. Front Immunol 16:1672072 PMID: 41030439
- 6. Noel PJ et al.. 1996. Regulation of T cell activation by CD28 and CTLA4.. Adv Exp Med Biol 406:209-17 PMID: 8910687
- 7. Pereira MS et al.. 2018. Glycans as Key Checkpoints of T Cell Activity and Function.. Front Immunol 9:2754 PMID: 30538706
- 8. Fang W et al.. 2021. Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8(+) T cell exclusion.. J Exp Clin Cancer Res 40(1):4 PMID: 33390170
